KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adaptive Biotechnologies (ADPT) Shares Outstanding: 2018-2025

Historic Shares Outstanding for Adaptive Biotechnologies (ADPT) over the last 8 years, with Sep 2025 value amounting to $152.6 million.

  • Adaptive Biotechnologies' Shares Outstanding rose 3.40% to $152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.6 million, marking a year-over-year increase of 3.40%. This contributed to the annual value of $147.8 million for FY2024, which is 1.86% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Shares Outstanding is $152.6 million, which was up 0.23% from $152.2 million recorded in Q2 2025.
  • Adaptive Biotechnologies' Shares Outstanding's 5-year high stood at $152.6 million during Q3 2025, with a 5-year trough of $139.9 million in Q1 2021.
  • Its 3-year average for Shares Outstanding is $147.8 million, with a median of $147.5 million in 2024.
  • Data for Adaptive Biotechnologies' Shares Outstanding shows a peak YoY increased of 10.47% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Adaptive Biotechnologies' Shares Outstanding stood at $141.4 million in 2021, then rose by 1.21% to $143.1 million in 2022, then grew by 1.38% to $145.1 million in 2023, then grew by 1.86% to $147.8 million in 2024, then increased by 3.40% to $152.6 million in 2025.
  • Its Shares Outstanding stands at $152.6 million for Q3 2025, versus $152.2 million for Q2 2025 and $151.9 million for Q1 2025.